AI assistant
Benchmark Holdings Plc — Remuneration Information 2020
Feb 25, 2020
6035_dirs_2020-02-25_b03e8f1f-979e-4d4f-a649-0c972cd06986.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0455E
Benchmark Holdings PLC
25 February 2020
25 February 2020
BENCHMARK HOLDINGS PLC
("Benchmark" or the "Company")
DIRECTOR SHARE OPTIONS
Benchmark Holdings plc announces that on 21 February 2020, and in accordance with the intention disclosed in its Annual Report and Accounts published on 18 December 2019, options over Ordinary Shares of 0.1 pence each ("Ordinary Shares") were granted to Alexander Raeber, Chief Scientific Officer and Septima Maguire, Chief Financial Officer, under the Company Share Option Plan (CSOP).
Options over a total of 275,000 Ordinary Shares were granted to Alexander Raeber; and options over a total of 400,000 Ordinary Shares were granted to Septima Maguire. Following this grant, Alexander Raeber remains interested in 207,658 Ordinary Shares and holds options over a total of 675,000 Ordinary Shares in the Company, representing approximately 0.03% and 0.1% of Benchmark's existing issued share capital respectively. Following this grant, Septima Maguire remains interested in 250,000 Ordinary Shares and now holds options over a total of 400,000 Ordinary Shares in the Company, representing approximately 0.04% and 0.06% of Benchmark's existing issued share capital respectively.
The options granted have a vesting period of three years, may be exercised up to the tenth anniversary of grant, have an exercise price of 42.5 pence per Ordinary Share, and are not subject to performance criteria.
Notification and public disclosure of transactions by persons discharging managerial responsibilities:
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Alexander Raeber
2
Reason for the notification
a)
Position/status
Chief Scientific Officer
b)
Initial notification/Amendment
Initial
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Benchmark Holdings plc
b)
LEI
n/a
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Options over 0.1p ordinary shares
ISIN: GB00BGHPT808
b)
Nature of the transaction
Issue of share options under Company Share Option Plan (CSOP)
c)
Price(s) and volume(s)
| Exercise price | Volume(s) |
| 42.5 pence | 275,000 |
d)
Aggregated information
- Aggregated volume
- Price
Volume: 275,000
Price: Nil
e)
Date of the transaction
21 February 2020
f)
Place of the transaction
Off exchange
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Septima Maguire
2
Reason for the notification
a)
Position/status
Chief Financial Officer
b)
Initial notification/Amendment
Initial
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Benchmark Holdings plc
b)
LEI
n/a
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Options over 0.1p ordinary shares
ISIN: GB00BGHPT808
b)
Nature of the transaction
Issue of share options under Company Share Option Plan (CSOP)
c)
Price(s) and volume(s)
| Exercise price | Volume(s) |
| 42.5 pence | 400,000 |
d)
Aggregated information
- Aggregated volume
- Price
Volume: 400,000
Price: Nil
e)
Date of the transaction
21 February 2020
f)
Place of the transaction
Off exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHUVSKRRRUUURR